Skip to content

Learn about our healthcare areas

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home /
  2. Our Company/
  3. Ending tuberculosis is good business
Doctor using a stethoscope to check a patient's lungs and heart
Our Company

Ending tuberculosis is good business

Did you know that Tuberculosis (TB) is the world’s deadliest infectious disease, killing more people in 2018 than HIV and malaria deaths combined? Learn how Johnson & Johnson and its partners are working to help eliminate TB by 2030 through a new workplace initiative aimed at raising awareness and increasing access to prevention, screening, diagnosis, treatment and care at the 2020 World Economic Forum Annual Meeting. Together, this initiative will potentially improve the health of hundreds of millions of lives.